News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
712,518 Results
Type
Article (43704)
Company Profile (261)
Press Release (668553)
Section
Business (207397)
Career Advice (2053)
Deals (35932)
Drug Delivery (94)
Drug Development (81263)
Employer Resources (172)
FDA (16732)
Job Trends (15219)
News (350832)
Policy (33678)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (6)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2600)
Accelerated approval (2)
Adcomms (20)
Allergies (81)
Alliances (50172)
ALS (84)
Alzheimer's disease (1364)
Antibody-drug conjugate (ADC) (108)
Approvals (16732)
Artificial intelligence (232)
Autoimmune disease (15)
Automation (14)
Bankruptcy (364)
Best Places to Work (11740)
BIOSECURE Act (18)
Biosimilars (101)
Biotechnology (181)
Bladder cancer (58)
Brain cancer (24)
Breast cancer (248)
Cancer (1999)
Cardiovascular disease (161)
Career advice (1716)
Career pathing (29)
CAR-T (139)
Cell therapy (396)
Cervical cancer (18)
Clinical research (65884)
Collaboration (768)
Compensation (449)
Complete response letters (20)
COVID-19 (2591)
CRISPR (35)
C-suite (210)
Cystic fibrosis (98)
Data (1954)
Decentralized trials (2)
Denatured (16)
Depression (39)
Diabetes (252)
Diagnostics (6409)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (112)
Drug pricing (95)
Drug shortages (25)
Duchenne muscular dystrophy (85)
Earnings (87285)
Editorial (31)
Employer branding (21)
Employer resources (146)
Events (113628)
Executive appointments (646)
FDA (17854)
Featured Employer (48)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (696)
Gene editing (96)
Generative AI (18)
Gene therapy (276)
GLP-1 (688)
Government (4460)
Grass and pollen (4)
Guidances (48)
Healthcare (19064)
Huntington's disease (22)
IgA nephropathy (22)
Immunology and inflammation (105)
Indications (27)
Infectious disease (2722)
Inflammatory bowel disease (131)
Inflation Reduction Act (8)
Influenza (47)
Intellectual property (86)
Interviews (316)
IPO (16657)
IRA (40)
Job creations (3902)
Job search strategy (1462)
Kidney cancer (9)
Labor market (34)
Layoffs (457)
Leadership (15)
Legal (8205)
Liver cancer (70)
Lung cancer (291)
Lymphoma (133)
Machine learning (4)
Management (58)
Manufacturing (265)
MASH (60)
Medical device (14241)
Medtech (14246)
Mergers & acquisitions (19746)
Metabolic disorders (634)
Multiple sclerosis (69)
NASH (16)
Neurodegenerative disease (76)
Neuropsychiatric disorders (24)
Neuroscience (1841)
NextGen: Class of 2025 (6665)
Non-profit (4505)
Northern California (2427)
Now hiring (37)
Obesity (340)
Opinion (204)
Ovarian cancer (72)
Pain (77)
Pancreatic cancer (76)
Parkinson's disease (135)
Partnered (20)
Patents (205)
Patient recruitment (94)
Peanut (46)
People (58033)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20524)
Phase II (29019)
Phase III (21621)
Pipeline (1025)
Podcasts (44)
Policy (110)
Postmarket research (2570)
Preclinical (8681)
Press Release (65)
Prostate cancer (94)
Psychedelics (30)
Radiopharmaceuticals (245)
Rare diseases (356)
Real estate (6084)
Recruiting (65)
Regulatory (22946)
Reports (46)
Research institute (2356)
Resumes & cover letters (353)
Rett syndrome (3)
RNA editing (4)
RSV (39)
Schizophrenia (64)
Series A (121)
Series B (79)
Service/supplier (13)
Sickle cell disease (50)
Southern California (2113)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (28)
Startups (3727)
State (2)
Stomach cancer (13)
Supply chain (59)
The Weekly (25)
United States (21289)
Vaccines (662)
Venture capitalists (38)
Webinars (12)
Weight loss (224)
Women's health (33)
Worklife (15)
Date
Today (229)
Last 7 days (708)
Last 30 days (2771)
Last 365 days (33910)
2025 (8044)
2024 (35522)
2023 (40454)
2022 (51577)
2021 (56211)
2020 (54685)
2019 (47319)
2018 (35669)
2017 (32989)
2016 (32696)
2015 (38720)
2014 (32437)
2013 (27586)
2012 (29812)
2011 (30439)
2010 (28447)
Location
Africa (754)
Alabama (50)
Alaska (7)
Arizona (229)
Arkansas (13)
Asia (39239)
Australia (6364)
California (5549)
Canada (1870)
China (476)
Colorado (249)
Connecticut (263)
Delaware (127)
Europe (83661)
Florida (819)
Georgia (193)
Idaho (57)
Illinois (506)
India (23)
Indiana (292)
Iowa (9)
Japan (142)
Kansas (100)
Kentucky (23)
Louisiana (8)
Maine (60)
Maryland (844)
Massachusetts (4180)
Michigan (210)
Minnesota (377)
Mississippi (2)
Missouri (75)
Montana (27)
Nebraska (25)
Nevada (58)
New Hampshire (65)
New Jersey (1575)
New Mexico (28)
New York (1594)
North Carolina (956)
North Dakota (7)
Northern California (2427)
Ohio (192)
Oklahoma (14)
Oregon (33)
Pennsylvania (1254)
Puerto Rico (9)
Rhode Island (26)
South America (1135)
South Carolina (18)
South Dakota (1)
Southern California (2113)
Tennessee (92)
Texas (829)
Utah (167)
Virginia (129)
Washington D.C. (58)
Washington State (514)
West Virginia (3)
Wisconsin (49)
712,518 Results for "908 devices inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices
March 4, 2025
·
8 min read
Press Releases
908 Devices Receives $1.7M Order from the Ministry of Health of Ukraine for its Handheld Mass Spec Device
March 11, 2025
·
3 min read
Press Releases
908 Devices to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
March 3, 2025
·
1 min read
Press Releases
908 Devices Announces Strategic Transformation and Reports Fourth Quarter and Full Year 2024 Financial Results
March 4, 2025
·
14 min read
Genetown
908 Devices to Participate in Upcoming Investor Conferences - May 15, 2024
908 Devices Inc. today announced it will participate in the following investor conferences.
May 15, 2024
·
1 min read
Press Releases
908 Devices Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results
January 15, 2025
·
3 min read
Genetown
908 Devices Trace Chemical Identification Technology Adopted by European Agencies
908 Devices Inc., a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces the latest in international adoption of the MX908 for trace detection and identification of priority drugs and chemical threats.
March 12, 2024
·
5 min read
Press Releases
908 Devices to Participate in Upcoming Investor Conferences
November 4, 2024
·
1 min read
Business
908 Devices Appoints Michele M. Leonhart, Former Administrator of the United States Drug Enforcement Administration (DEA), to Its Board of Directors
908 Devices Inc. has appointed Michele M. Leonhart, the former Administrator of the United States Drug Enforcement Administration (DEA), to serve on its Board of Directors effective immediately.
June 25, 2024
·
4 min read
Business
908 Devices to Report First Quarter 2024 Financial Results on April 30, 2024
908 Devices Inc. today announced it will report financial results for the first quarter 2024 before market open on Tuesday, April 30, 2024.
April 23, 2024
·
1 min read
1 of 71,252
Next
